PMGC Holdings ELAB
NASDAQ ELAB
$2.78 -0.03 (-1.06%)
As of: Oct 21, 2026 · 3:47 PM EDT

PMGC Holdings (ELAB) Operating Interest Expenses (2025)

Updated

PMGC Holdings (ELAB) reported Operating Interest Expenses of $179,479 for Q3 2025.

Analysis

PMGC Holdings (ELAB) Operating Interest Expenses (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 PMGC Holdings 1.36 Mn -47.00 Mn 385,691.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 179,479.00
API Access

PMGC Holdings Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=ELAB&period=max&api_key=YOUR_API_KEY